Two most common properties of malignant cells are the presence of aberrant actin cytoskeleton and resistance to anoikis. Suppression of several key cytoskeletal proteins, including tropomyosin-1 (TM1), during neoplastic transformation is hypothesized to contribute to the altered cytoskeleton and neoplastic phenotype. Using TM1 as a paradigm, we have shown that cytoskeletal proteins induce anoikis in breast cancer (MCF-7 and MDA MB 231) cells. Here, we have tested the hypothesis that TM1-mediated cytoskeletal changes regulate integrin activity and the sensitivity to anoikis. TM1 expression in MDA MB 231 cells promotes the assembly of stress fibers, induces rapid anoikis via caspase-dependent pathways involving the release of cytochrome c. Further, TM1 inhibits binding of MDA MB 231 cells to collagen I, but promotes adhesion to laminin. Inhibition of Rho kinase disrupts TM1-mediated cytoskeletal reorganization and adhesion to the extracellular matrix components, whereas the parental cells attach to collagen I, spread and form extensive actin meshwork in the presence of Rho kinase inhibitor, underscoring the differences in parental and TM1-transduced breast cancer cells. Further, treatment with the cytoskeletal disrupting drugs rescues the cells from TM1-induced anoikis. These new findings demonstrate that the aberrant cytoskeleton contributes to neoplastic transformation by conferring resistance to anoikis. Restoration of stress fiber network through enhanced expression of key cytoskeletal proteins may modulate the activity of focal adhesions and sensitize the neoplastic cells to anoikis.
Introduction
It is well established that the interactions of cells with their surroundings exert profound influence on cell phenotype (Schmeichel et al., 1998; Bissell and Radisky, 2001; Chrenek et al., 2001; Haslam and Woodward, 2003; Shekhar et al., 2003) . The growth and differentiation of normal epithelial cells is dependent on survival signals that are activated by the interactions of adhesion molecules and the extracellular matrix (ECM) compounds (Schwartz, 1997; Frisch and Screaton, 2001) . Under normal growth conditions, integrins are activated following binding to ECM, which in turn, activates a large number of diverse intracellular events (DeMali et al., 2003) . These events include the assembly of focal adhesions, actin microfilament reorganization and recruitment of a number of signaling molecules to the focal adhesions. Although the precise mechanisms need to be completely delineated, the reorganized cytoskeleton is believed to transduce integrin-derived signals to promote growth and differentiation . However, cells rapidly undergo apoptosis when deprived of the adhesion-derived signals, in a process termed anoikis (Frisch and Screaton, 2001) . Consequently, survival is ensured only when cells are in their physiological environment. Thus, anoikis plays a key role during normal growth and differentiation, as illustrated in tubulogenesis of mammary epithelial cells (Debnath et al., 2002 (Debnath et al., , 2003 and wound healing (Manohar et al., 2004) .
Most malignant cells, however, are resistant to anoikis, and thus are able to survive in a nonphysiological environment and thrive as metastases. Some studies have suggested that resistance to anoikis is acquired early on during the neoplastic growth (Debnath et al., 2002; Swan et al., 2003) . Several mechanisms have been suggested to contribute to the resistance of anoikis in malignant cells. For example, activation of oncogenes (Coll et al., 2002) , growth factors (Rosen et al., 2001; Normanno et al., 2004) and modulation of integrin activity (Strater et al., 1996; Kozlova et al., 2001; Janes and Watt, 2004) , which result in the activation of a plethora of mitogenic and survival signaling, have been shown to confer resistance to anoikis in malignant cells. However, fewer studies have examined the mechanisms/ agents that resensitize tumor cells to anoikis. Restoration of the expression of tumor suppressor genes, such as PTEN (Davies et al., 1998; Lu et al., 1999) and p16
INK4a (Plath et al., 2000; Rocco and Sidransky, 2001 ), have been reported to induce anoikis.
One of the most prominent features of malignant cells is the presence of altered actin cytoskeleton, arising from the suppression of several key actin-binding proteins, such as profilin, a-actinin, tropomyosins (TMs) (reviewed in Lin et al., 1997; Pawlak and Helfman, 2001 ). The aberrant cytoskeleton contributes to neoplastic growth in several ways including through increasing resistance to apoptosis (Martin and Leder, 2001) . However, it is unresolved whether the tumor cell cytoskeleton plays a role in conferring adhesionindependent survival.
Work from this and other laboratories has identified that the tropomyosin isoform-1 (TM1), is consistently suppressed in breast cancer cell lines (Bhattacharya et al., 1990) and breast tumors (Raval et al., 2003) , and is downregulated in urinary bladder tumors (Pawlak et al., 2004) , suggesting that the loss of TM1 may contribute to the neoplastic transformation. Restoration of TM1 expression in several oncogene-transformed (Prasad et al., 1993 (Prasad et al., , 1999 Braverman et al., 1996) and spontaneously transformed breast cancer cells (Mahadev et al., 2002; Raval et al., 2003) reorganizes microfilaments, forms stress fibers in a Rho-kinase-dependent fashion (Shah et al., 2001 ) and suppresses the anchorage-independent growth. Further investigations have revealed that TM1 induces anoikis in breast cancer cells, and thus may suppress their malignant behavior (Mahadev et al., 2002; Raval et al., 2003) . Since TMs stabilize actin cytoskeleton (reviewed in Cooper, 2002) and regulate actin-myosin interactions (reviewed in Marston et al., 1998) , we have hypothesized that TM1-mediated cytoskeletal reorganization is critical for the antineoplastic effects of TM1 (Bharadwaj et al., 2004) .
In this work, we have sought to determine whether the cytoskeletal organization modulates the sensitivity to anoikis. We have utilized TM1-mediated cytoskeletal changes as a paradigm to investigate the mechanisms of resensitization of tumor cells to anoikis. Consistent with the predominant role of integrins in adhesion-dependent signaling, and that TM1 promotes detachment-induced apoptosis, we have found that TM1 modulates the expression and activity of integrins in breast cancer cells, which may be important in TM1-induced anoikis. Our work demonstrates that cytoskeletal organization is a key determinant of adhesion-dependent cell survival.
Results

TM1
promotes microfilament reorganization and cell-spreading in breast cancer cells TM1-induced anoikis is markedly rapid in MDA MB 231 cells in serum-free media, and we have used this cell type as a model (Raval et al., 2003) . Since TM1 is a microfilament-stabilizing protein that promotes stress fiber assembly (Prasad et al., 1993 (Prasad et al., , 1999 Mahadev et al., 2002) , we have first examined whether TM1 reorganizes microfilaments in MDA MB 231 cells. Parental MDA MB 231 cells, which lack TM1 expression (Bhattacharya et al., 1990; Bharadwaj and Prasad, 2002; Mahadev et al., 2002) , are spindle shaped and grow as dispersed cells in monolayer cultures. Restoration of TM1 expression, however, produces marked changes in the cellular morphology. The cells transduced with TM1 (MDA MB 231/TM1) ( Figure 1a ) appear well spread and grow as groups of cells, features that are consistent with normal epithelial cell growth (Figure 1b) . Whereas the parental cells lack stress fibers, TM1 expression reorganizes the cytoskeleton as evident from the emergence of stress fibers (Figure 1c ). Cells transfected with empty vector (MDA MB 231/V cells) resemble the parental cells morphologically (not depicted), and behave similarly as the unmodified MDA MB 231 cells in the following experiments. We routinely analyze two independent clones of MDA MB 231/TM1 cells.
TM1 induces anoikis in breast cancer cells in normal growth media
Previously we have shown that transduction of breast cancer cells with TM1 induces anoikis when cultured in serum-free media (Raval et al., 2003) . Since both growth factor-and adhesion-derived signaling pathways are necessary for normal cell survival, and malignant cells appear primarily dependent on growth factors (serum) Restoration of TM1 expression alters cellular morphology and promotes stress fiber assembly: (a) MDA MB 231 cells were retrovirally transduced with TM1 and the isolated cell lines were tested for TM1 expression using a TM1-specific antibody. The parental cells are negative for TM1 expression whereas two independent clones are positive. The blot was probed with tubulin antibody for load controls. (b) Light microscopic examination ( Â 20 magnification shown) reveals that the parental cells display spindle shaped morphology, while MDA MB 231/TM1 cells grow as tight clusters with increased cell spreading. (c) TM1 expression results in the reorganization of microfilaments and promotes stress fiber assembly as determined by immunostaining with TM polyclonal antibody (green) and Texas-Red-conjugated phalloidin followed by confocal microscopy. MDA MB 231 cells lack stress fibers
Anoikis by tropomyosin S Bharadwaj et al for survival (Schwartz, 1997) , we examined whether TM1-induced anoikis can be overcome by culturing in normal growth media. The cells were cultured in serumfree medium (Raval et al., 2003) , or in regular growth media containing 1 or 10% of fetal bovine serum on poly-HEMA-coated plates for 6 and 24 h, and the anoikis was determined by measuring the DNA content in the sub-G 0 -G 1 phase of cell cycle. Survival of unmodified MDA MB 231 cells in suspension cultures is not affected by the presence or the absence of serum, as indicated by the background levels of DNA in the sub-G 0 -G 1 phase of cell cycle (Table 1) . TM1 expression, however, induced significant anoikis by 6 h in serumfree as well as in normal growth conditions, and massive apoptosis was detected by 24 h, and therefore all the subsequent experiments were performed in regular growth medium. This finding underscores the essential requirement of adhesion-dependent signaling, but not of growth factor-derived signals, in sustaining the survival of TM1-transduced breast cancer cells. Thus, resensitization of tumor cells to anoikis appears to be a key mechanism of the antineoplastic activity of TM1.
We have further characterized TM1-induced anoikis by fragmented nuclear morphology (Figure 2a and b) , increased annexin V staining ( Figure 2c ) and PARP cleavage (Figure 2d ). These data suggest that TM1 renders breast cancer cells dependent on adhesionderived survival signals, and growth factors (serum) fail to rescue the cells from TM1-induced anoikis.
TM1-induced anoikis is mediated through the intrinsic death pathway in a caspase-dependent fashion Anoikis is known to be mediated through the extrinsic (death receptor-mediated) and the intrinsic (mitochondrial) pathways of cell death (Aoudjit and Vuori, 2001; Valentijn et al., 2003) . To determine the pathways through which TM1 induces anoikis, we have determined mitochondrial integrity which is an indicator of the intrinsic pathways of apoptosis. Mitochondrial integrity has been measured by immunofluorescence and immunoblotting methods. In normal cells, cytochrome c is contained in mitochondria as revealed by punctate staining in MDA MB 231 cells under suspension culture for 24 h (Figure 3a) . However, mitochondrial integrity of MDA MB 231/TM1 cells cultured in suspension is breached, as evident from the patchy staining and the release of cytochrome c into the cytoplasm. These results are substantiated by immunoblotting data which show that cytochrome c is released into the cytoplasm of MDA MB 231/TM1 cells cultured in suspension for 6 or 24 h, but not in the adherent cells. In MDA MB 231 cells cultured in suspension or as adherent populations, cytochrome c is not present in post-mitochondrial supernatants (Figure 3a , lower panel). Treatment of both cell types with cis-Platinum, however, resulted in the release of cytochrome c.
Next, we have determined the activities of the caspases that mediate cell death pathways. As shown in Figure 3b , cell detachment triggers the activation of caspases 3 and 7 in MDA MB 231/TM1 cells by 6 h of suspension culture, whereas the adherent cells do not contain the active caspases. The unmodified MDA MB 231 cells lack caspase activation in monolayer or in suspension, which is in agreement with their resistance to anoikis. The expression of caspase 8, which plays a critical role in the extrinsic pathways of cell death (Budihardjo et al., 1999; Kruidering and Evan, 2000) , is lacking in MDA MB 231/TM1 cells (data not shown).
Treatment of the parental and MDA MB 231/TM1 cells with etoposide, however, activated the caspases leading to apoptosis of the adherent cells. Consistent with the role of caspases in anoikis, inhibition of caspases with a broad specificity inhibitor rescued MDA MB 231/TM1 cells from anoikis (Figure 3c and d). Collectively, these data suggest that TM1-induces anoikis through the intrinsic death pathways.
TM1 modulates the expression and the activities of integrins in breast cancer cells
A large body of work (recently reviewed in Guo and Giancotti, 2004) suggests that integrins play a key role in malignant transformation. Deprivation of integrinderived survival signals is believed to trigger anoikis (reviewed in Frisch and Screaton, 2001; Stupack and Cheresh, 2002) . Consistently, modulation of the expression and the activities of integrins have been known to alter the susceptibility of cells to anoikis (Strater et al., 1996; Kozlova et al., 2001; Janes and Watt, 2004) . To investigate whether TM1-induced anoikis is mediated through modulation of integrin expression/activity, we first determined the adhesion of MDA MB 231/TM1 cells to the ECM components.
MDA MB 231 cells and the vector control cells bound to collagen very efficiently (Figure 4a ). The binding of MDA MB 231/TM1 cells to collagen, however, was significantly suppressed (50-70%). In contrast, cell adhesion to laminin was markedly (about threefold) Cells were cultured for the indicated times and anoikis was determined by quantifying DNA in the sub-G 0 ÀG 1 fraction of cell cycle
Anoikis by tropomyosin S Bharadwaj et al enhanced by TM1 expression, whereas binding to fibronectin was modestly enhanced. Nonintegrinmediated binding, as measured by adhesion to poly-Llysine-coated surfaces was comparable in all the cell lines. Further, we examined whether TM1-mediated inhibition of adhesion to collagen I was specific by testing binding to collagen I and collagen IV. Adhesion of MDA MB 231/TM1 cells to collagen I was inhibited, whereas the parental and TM1-transduced cells bound equally well to collagen IV ( Figure 4b ). We next investigated whether the differential binding properties of MDA MB 231/TM1 cells results in distinct organization of microfilaments. As shown in Figure 4c and d, parental MDA MB 231 cells spread well on collagen I and laminin, form lamellipodia and stain intensely for cortical F-actin. MDA MB 231/TM1 cells, upon attachment to ECM, form stress fibers, indicating that TM1 primarily promotes the formation of stress fibers even under conditions of poor cell adhesion as observed on collagen I. These data indicate that TM1 expression modulates cell adhesion to the ECM components, possibly through regulating the expression and activity of integrins.
Cell adhesion to ECM is mediated through the heterodimeric transmembrane integrin receptors. Since TM1 modulates adhesion to collagen I and laminin, we investigated whether the expression of collagen-and laminin-binding integrins is altered. The a 2 b 1 integrin is a major collagen receptor (Heino, 2000) and is prominently expressed in MDA MB 231 cells (Maemura et al., 1995) . Flow cytometric analysis showed that both a 2 and b 1 subunits are present on MDA MB 231 cells. The cell surface expression of a 2 and b 1 integrins is markedly downregulated in MDA MB 231/TM1 cells, indicating that the downregulation of these integrins correlated with the reduced adhesion of these cells to collagen I (Figure 5a ). In agreement with flow cytometry data, immunoblotting shows that the a 2 and b 1 integrins are downregulated in TM1-transduced cell lines (Figure 5b ). To determine whether the a 2 b 1 integrin mediates the reduced adhesion to collagen in TM1-transduced cells, we have utilized the function-blocking antibodies. Preincubation with blocking antibodies against a 2 or b 1 integrin chains significantly inhibited the binding of MDA MB 231 cells (Figure 6a ). The binding of one of the MDA MB 231/TM1 cell lines, which showed a 50% reduction in binding to collagen (compared to the parental cells), was further reduced by the blocking antibodies. The attachment of the second cell line, which binds to collagen I very poorly, however, was not further reduced by the blocking antibodies.
We have tested whether the stimulatory antibody TS2/16 increases the binding of control and TM1-transduced cells to collagen I. The binding of parental MDA MB 231 cells to collagen I matrix was enhanced by about 50%. The poor cell adhesion of MDA MB 231/TM1 cells to collagen I, however, was not enhanced by the activating antibodies of b 1 integrin (data not shown), possibly due to the downregulation of the integrin.
Since MDA MB 231/TM1 cells bind to laminin more efficiently than the parental cells (Figure 4a ) but exhibit a downregulation of b 1 integrin expression, we examined To distinguish between these possibilities, we have preincubated the cells with function-blocking antibodies and tested for adhesion to laminin. The poor binding of MDA MB 231 cells to laminin was not further inhibited by the inhibitory antibodies against a 6 and b 4 integrins (Figure 6b) . However, the blocking antibodies against a 6 and b 4 integrins reduced binding of MDA MB 231/TM1 cells to laminin by 50%, indicating that the low levels of the a 6 b 4 integrin is highly active in mediating adhesion to laminin.
Since the downregulation of several a integrins in MDA MB 231/TM1 cells (Figure 5a) , it is likely that MDA MB 231/TM1 cells may utilize other integrins (e.g., a 9 b 1 integrin; Palmer et al., 1993) as a laminin receptor. Our preliminary results showed that the TM1-transduced cells elaborate significantly higher expression of a 9 b 1 integrin (Figure 5a ).
In addition, we find that the expression of a 5 and b 5 integrins is upregulated significantly in TM1-transduced cells (Figure 5a ). These results are in agreement with the published work which showed that b 5 integrin induces anoikis (Janes and Watt, 2004) , and the a 5 integrins suppresses the transformed phenotype (Giancotti and Ruoslahti, 1990) . Taken together, our results indicate that the restoration of TM1 expression in breast cancer cells results in the altered expression and activity of integrins.
Role of TM1-induced cytoskeleton in adhesion to ECM
MDA MB 231 cells lack stress fibers (Figure 1c) , whereas the re-expression of TM1 promotes the forma- (Figure 7a) , and severely disrupted the microfilament organization and resulted in the formation of patches of F-actin (Figure 7b , right panel). Thus, malignant breast cancer cells appear to bind more efficiently and undergo cytoskeletal rearrangements on collagen when Rho kinase is inhibited, whereas the cells transduced with TM1 are dependent on Rho kinase activity for maximal binding to the ECM and stress fiber formation. Inhibition of Rho kinase during adhesion to laminin also produced a decreased binding in MDA MB 231/TM1 cells, although to a lesser extent, and in disruption of microfilaments (data not shown). Together, these results show that cells expressing TM1 are dependent on Rho kinase signaling for stress fiber assembly and adhesion to ECM. 
Cytoskeletal disruption rescues breast cancer cells from TM1-induced anoikis
One of the most prominent consequences of restoration of TM1 in malignant cells is the reorganization of actin microfilaments. While detachment of cells from the substratum results in the disorganization of prominent cytoskeletal structures such as stress fibers, it is likely that the residual cytoskeleton may be effective in inducing anoikis. To determine the importance of TM1-induced cytoskeleton in resensitizing breast cancer cells to anoikis, we tested whether disruption of actin cytoskeleton would rescue cells from anoikis.
We have utilized Y-27632 and latrunculin A (LatA) to disrupt cytoskeleton and tested whether MDA MB 231/ TM1 cells can be rescued from anoikis. Addition of either of the drugs resulted in a near 50% decrease in the DNA content in the sub-G 0 -G 1 fraction of cell cycle, suggesting a role for cytoskeleton in sensitizing tumor cells to anoikis (Figure 8 ). The presence of drugs, however, did not influence the anoikis resistance of parental breast cancer cells, and the cells remained resistant to anoikis. These results suggest that TM1-induced cytoskeletal changes are involved in inducing anoikis in breast cancer cells.
Discussion
Resistance to anoikis is an important property acquired early on during neoplastic transformation that facilitates the survival of tumor cells in the absence of normal adhesion-dependent signaling. Therefore, mechanisms that trigger anoikis in tumor cells are of potential interest in designing antitumor therapies. The key finding of this study is that the microfilament-associated proteins and actin cytoskeletal organization are critical determinants of the sensitivity to anoikis. Our work, using TM1 as a paradigm, suggests that tumor cells can be sensitized to anoikis by cytoskeletal reorganization. Further, TM1 alters integrin expression and activity, which may contribute to the anoikis.
The present study demonstrates that restoration of TM1 expression reinstates a strict requirement of adhesion-dependent signals for cell survival, whereas our previous work (Raval et al., 2003) has shown that TM1 induces anoikis in growth factor-deficient media. Accordingly, growth factor (serum) supplementation is unable to rescue TM1-transduced breast cancer cells from anoikis. This phenotype is similar to that of normal mammary epithelial cells which undergo anoikis (Gilmore et al., 2000; Schulze et al., 2001) . Restoration of TM1 expression, however, does not alter the response of the breast cancer cells to other apoptotic stimuli such as cis-Platinum (Figure 3a However, anoikis of mammary epithelial cells progresses through the intrinsic pathways of apoptosis through cytochrome c release from mitochondria (Valentijn et al., 2003) . TM1-mediated anoikis is also dependent on caspase activation and occurs through the intrinsic pathways of cell death (Figure 3) . Based on the biochemical functions of TMs, we propose that TM1 exerts its antioncogenic effects through the reorganization of cytoskeleton (Figure 9 ). According to this model, TM1 reorganizes cytoskeleton, promotes stress fiber assembly and modulates intracellular signaling pathways, leading to altered cell-ECM interactions. Consequently, adhesion dependency is restored for cell survival.
Role of cytoskeleton in TM1-induced anoikis
It is intriguing that a structural protein, like TM1, with no known catalytic activity, exerts a profound effect on cell growth. Although some studies indicate that TMs binds to other noncytoskeletal regulatory proteins (Li et al., 2003) , it is unclear whether such interactions are important for TM1 functions. Therefore, we have reasoned that the antioncogenic functions of TM1 are dependent on its ability to reorganize the cytoskeleton. Further, TM isoforms (Braverman et al., 1996; Raval et al., 2003) or variants of TM1 (Bharadwaj et al., 2004) that fail to induce cytoskeletal changes do not function as suppressors of neoplastic growth. Reorganization of microfilament architecture by TM1 is likely to be mediated through two distinct mechanisms. First, TM1, in conjunction with caldesmon, primarily stabilizes actin microfilaments against the action of gel severing and depolymerizing proteins such as gelsolin and cofilin (Cooper, 2002) . Second, TMs regulate actinmyosin interactions (Marston et al., 1998) , inhibit actomyosin ATPase activity and modulate cellular contractility. It has been suggested that the downregulation of cytoskeletal proteins in neoplastic transformation may promote cellular contractility and destabilize focal adhesions (Pawlak and Helfman, 2001 ), whereas inhibition of cellular contractility in ras-transformed cells results in a partial revertant phenotype (Zhong et al., 1997) .
Whereas it is well established that reorganization of actin cytoskeleton occurs upon activation of adhesiondependent signaling (DeMali et al., 2003) , it is not well understood if the cytoskeletal changes are important in resistance to anoikis. Rac and Cdc42, which primarily control the assembly of lamellipodia and filopdia, respectively, are reported to confer resistance to anoikis (Coniglio et al., 2001; Cheng et al., 2004) . It remains to be determined whether RhoA, which in normal cells controls the assembly of stress fibers and focal adhesions, has any role in anoikis. Data presented here (Figures 7 and 8 ) and elsewhere (Shah et al., 2001) demonstrate that TM1-induced cytoskeletal changes are mediated through Rho-kinase-regulated pathways, and that Rho kinase signaling may be important in TM1-induced anoikis. However, in malignant cells, RhoA has been suggested to be uncoupled from its downstream effectors which may explain the lack of stress fibers in transformed cells (Izawa et al., 1998; Sahai et al., 2001; Pawlak and Helfman, 2002) .
We have hypothesized that the cytoskeletal reorganization by TM1 as the key to induction of anoikis ( Figure 9 ). The cytoskeletal disrupting drugs, such as LatA, induce apoptosis in normal MCF10A cells (Martin and Leder, 2001 ). In our hands treatment of MDA MB 231/TM1 cells with much reduced amounts of LatA (0.5 mM) disrupted the cytoskeletal organization, abolished binding to collagen I in adherent cells. Disruption of cytoskeleton by LatA and the Y compound rescues breast cancer cells from TM1-induced anoikis (Figure 8 ), which suggests a role for cytoskeleton. Confocal microscopic examination of the parental and TM1-transduced cells in suspension, however, revealed no readily discernible cytoskeletal structures (data not shown). Although adhesion-deprived cells lack extensive cytoskeletal structures like stress fibers, they may contain a residual cytoskeleton. The cytoskeletons of normal (anoikis-sensitive) and malignant (anoikis-resistant) cells may differ in their composition, bundling status and their interaction with 
Adhesiondependent signaling
Sensitivity to anoikis
Resistance to anoikis Figure 9 Hypothetical events in TM1-induced anoikis. Most tumor cells contain aberrant cytoskeleton, constitutively active integrins and deregulated intracellular signaling resulting in an anoikis-resistant phenotype (depicted with gray arrows). We propose that TM1 expression results in the reorganization of cytoskeleton with the assembly of stress fibers, leading to altered intracellular signaling pathways and integrin expression and activation. Thus, the adhesion dependency on survival pathways is restored and the tumor cells are resensitized to anoikis (depicted with solid arrows). The TM1-induced microfilaments are critical for the induction of anoikis
Anoikis by tropomyosin S Bharadwaj et al focal adhesions. Such biochemical differences may modulate focal adhesion-derived signaling pathways (regulated by focal adhesion kinases) and regulate cell survival. Stress fibers are assembled under the control of RhoA-Rho kinase signaling (Chrzanowska-Wodnicka and Burridge, 1996; Amano et al., 1997) . One of the important downstream targets of Rho kinase signaling is cofilin. Rho kinase, through LIM kinase, promotes the phosphorylation and inactivation of cofilin, which results in the stabilization of actin filaments (reviewed in Bamburg and Wiggan, 2002; Dos Remedios et al., 2003) . The TM1-mediated cytoskeletal rearrangements are dependent on sustained Rho kinase signaling (Figure 7b and Shah et al., 2001) . Recent work from this laboratory shows that TM1 inhibits the activity and limits the access of cofilin to actin cytoskeleton and thus protects the cytoskeleton (Bharadwaj et al., 2004) . Thus, the ability of TM1 to reorganize cytoskeleton is mediated through Rho kinase, and that Rho kinase signaling may be important in TM1-induced anoikis.
Role of integrins in TM1-induced anoikis
Integrins and microfilaments have been proposed to engage in bidirectional signaling and regulate cell growth and differentiation (Schoenwaelder and Burridge, 1999) . Further, integrins are key modulators of anoikis (Caruso and McIntyre, 2001; Kozlova et al., 2001; Marco et al., 2003; Janes and Watt, 2004) . Whereas integrin activation promotes cytoskeletal reorganization through Rho GTPase-controlled pathways (reviewed in DeMali et al., 2003) , the present work shows that microfilament integrity is an important determinant in regulating anoikis and that the cytoskeleton may influence integrin expression/activity. Key cytoskeletal proteins, such as vinculin and talin, interact with F-actin and the cytoplasmic tails of integrins at the focal adhesions. These proteins have been known to regulate integrin activity, cytoskeletal reorganization and signaling pathways (Calderwood et al., 2000; Critchley, 2000) . Consistently, a recent study has shown that vinculin regulates FAK activation and anoikis (Subauste et al., 2004) . However, TMs bind to F-actin but are not known to associate with focal adhesions. Therefore, we hypothesize that TM1-induced cytoskeletal changes may regulate intracellular signaling, integrin expression and activity, and cell survival (Figure 9 ).
Neoplastic cells exhibit altered integrin expression and activation that may result in the constitutive activation of cell survival pathways independent of ECM-mediated integrin activation. TM1 induces anoikis in both serum-free (Raval et al., 2003) and serumcontaining media (Table 1 ), indicating that TM1 restores the requirement of adhesion-dependent signaling. Since integrins are key mediators of adhesiondependent signaling and that TM1 expression alters the expression and activities of integrins ( Figure 5 ), it is likely that TM1-induced anoikis involves modulation of activity and/or expression of integrins. Such a mechanism will be consistent with the previous research which suggests integrins as key modulators of anoikis (Strater et al., 1996; Kozlova et al., 2001; Janes and Watt, 2004) .
Investigation into the role of integrins revealed that TM1 expression inhibits the activity of collagen Ibinding integrins and upregulation of the activity of laminin receptors. The downregulation of a 2 b 1 integrin, a major collagen receptor, may explain in the poor binding to collagen I. We find that TM1 expression profoundly downregulates the expression of a 2 integrin. The expression of a 2 integrin is enhanced in Raf-induced resistance to anoikis of mammary epithelial cells (Schulze et al., 2001) . Further, Src-induced cell adhesion of breast cancer is reported to be mediated through a 2 integrin (Park et al., 2004) . Although enhanced expression of this integrin is observed in anoikis resistance (Schulze et al., 2001 ) and shown to be critical in mammary carcinogenesis (White et al., 2004) , the expression of this integrin is downregulated in many breast tumors (Alford et al., 1998) . At present, it is unclear whether downregulation of a 2 b 1 integrin contributes to TM1-induced anoikis.
Notwithstanding the increased binding to laminin, MDA MB 231/TM1 cells, these cells contained significantly reduced amounts of the laminin binding a 6 b 4 integrin. The a 6 b 4 integrin has been shown to be an important determinant in regulating tumor cell survival and motility (reviewed in Mercurio et al., 2001; Chung et al., 2004) . Currently, work is in progress to determine whether other integrins (e.g., a 9 b 1 ) promote TM1-mediated enhancement of binding to laminin. At present we do not exclude the participation of other integrins in TM1-induced anoikis. For example, TM1 transduced cells, like the parental MDA MB 231 cells, express readily detectable amounts of a 3 integrin. MDA MB 231/TM1 cells express elevated a 5 and b 5 integrins (Figure 5a ) which may regulate anoikis. The enhanced expression a 5 and b 5 integrins in the MDA MB 231/ TM1 cells is in agreement with the published antineoplastic roles of these integrins (Giancotti and Ruoslahti, 1990; Plath et al., 2000; Janes and Watt, 2004 ). While we find specific changes in the integrin profile and activity in TM1-transduced cells, further work is required to determine whether the observed changes in the expression/activity of integrins directly contribute to TM1-induced anoikis.
Alternatively, TM1-containing microfilaments may differ from the aberrant microfilaments present in unmodified MDA MB 231 cells in as yet unknown ways, and hence, fail to transduce survival signals from unligated integrins. Therefore, disruption of ECMintegrin-cytoskeletal interactions may be adequate to trigger anoikis in TM1-expressing cells.
A key question that remains to be addressed in this model (Figure 9 ) is how does the cytoskeleton regulate the expression and the activities of integrins? The cytoskeleton may anchor the key signaling enzymes or their substrates (Christerson et al., 1999; Fincham et al., 2000; Woodring et al., 2001) , regulate the subcellular distribution of the enzymes or the polymerization status of actin itself may act as a regulator of gene expression (Fincham et al., 2000; Woodring et al., 2001 Woodring et al., , 2002 Geneste et al., 2002) . Elucidation of the mechanisms that drive the changes in gene expression following the expression of TM1 in breast cancer cells are under investigation.
In summary, we show that restoration of TM1 expression promotes stress fiber assembly, alters integrin expression and activity and induces anoikis through intrinsic pathways of apoptosis. Our work suggests that downregulation of key cytoskeletal proteins, including TM1, during neoplastic transformation of mammary epithelia results in the formation of aberrant cytoskeleton. The aberrant cytoskeleton, in addition to the other well-recognized features of malignant phenotype, such as enhanced motility and invasive behavior, contributes to anoikis resistance and neoplastic growth.
Materials and methods
Cell lines and reagents
Culture conditions for MDA MB 231 and MDA MB 231/TM1 cells have been previously described (Raval et al., 2003) . The ECM components, rat tail collagen-I, collagen-IV, mouse laminin I and fibronectin, were purchased from BD Biosciences. Poly-L-lysine was obtained from Sigma. Anti-integrin antibodies for determining integrin expression were obtained from Chemicon: a 2 (P1E6), b 1 (clone HB1.1), a 6 (clone NKIGoH3) and a 9 b 1 integrin (clone Y9A2). The integrin antibodies direct to b 4 and a 6 subunits (439-9B and 135-13C) were from Rita Falcioni (Falcioni et al., 1988) . Caspases 3, 7, 8 and PARP were purchased from Cell Signaling. Caspase inhibitor, Z-Val-Ala-Asp-CH 2 F (Z-VAD), was purchased from Calbiochem and the stock solution prepared in DMSO. Cytocrome c antibody 7H8.2C12 was purchased from BD PharMingen. Texas-red-conjugated phalloidin was obtained from Molecular Probes. Tropomyosin-1 cDNA was cloned from LS-174t colon carcinoma cells (Prasad et al., 1991) and was subcloned into pBNC retroviral vector at a unique BamHI site (Prasad et al., 1993) .
Immunoblotting
Cytoplasmic cell lysates were prepared by NP40/DOC buffer (Bharadwaj et al., 2004) and total cell lysates were prepared using SDS buffer (2% SDS, 10 mM Tris-HCl pH 8.0, 1 mM sodium vanadate, 10 mM sodium fluoride and 100 mM bglycerophosphate). The SDS-solubilized lysates were sonicated with a Branson sonifier-250 (six pulses with microtip at 50% duty cycle and output control at 5) to reduce viscosity. Gel electrophoresis was carried out under nonreduced conditions for detecting integrins a 2 and b 1 . TM expression was determined by a pan-TM antibody prepared in house (Mahadev et al., 2002) . We also used antipeptide antibody raised against a specific sequence of TM1 molecule that does not react with other TM molecules (Mahadev et al., 2002) . The membranes were probed with antibodies against a-tubulin or b-actin (Sigma) as load controls.
To detect cytocrome c released from mitochondria, cytosolic fractions were prepared as follows. The cells (5 Â 10 6 ) were plated on poly-(2-hydroxyethyl methacrylate) (Poly-HEMA) as described below, washed in PBS and suspended in 250 ml of buffer containing 250 mM sucrose, 50 mM Pipes-NaOH (pH7.4), 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1mM DTT, 1 mM PMSF and protease inhibitors. After 30 min on ice, the cells were lysed with 10 strokes using homogenizer.
After centrifugation at 14 000 g for 15 min, the cytosolic fraction was collected. Equal volumes of each cytosolic fraction, containing 40 mg of proteins, were separated on 15% SDS-PAGE and subjected to Western Blot analysis.
Cell adhesion assays
Twenty-four-well culture plates (Costar) were coated with 200 ml of ECM components (collagen-I, collagen-IV, laminin or fibronectin) at a concentration of 50 mg/ml for 1 h at room temperature with constant shaking. Poly-L-lysine (100 mg/ml) was used for determining nonintegrin-mediated adhesion. The coated wells were washed thrice with PBS and blocked in 200 ml of 2% BSA in PBS for 1 h at 371C. The blocked wells were washed thrice with PBS. Cell adhesion assay was performed by plating 2 Â 10 5 cells in 1.0 ml of serum-containing medium for 30 min at 371C as described by Dickson's group (Maemura et al., 1995) . Briefly, the attached cells were stained with 200 ml of crystal violet solution (0.05% w/v in 25% methanol) for 10 min, washed thrice by immersion in water and air-dried. The samples were solubilized in 500 ml of 0.1 M sodium citrate solution and 50% ethanol (v/v) for 5 min and the absorbance was read at 540 nm using a Bio-Rad Smartspec 3000 spectrophotometer. Photomicrographs of bound cells were captured on a Zeiss inverted microscope with a Â 40 objective.
In experiments involving the use of inhibitors or antibodies, cells were pretreated for 60 min prior to the adhesion assay. The Rho kinase inhibitor, Y-27632 (Yoshitomi Pharmaceuticals), was used at 20 mM (TS2/16 (Pierce)), at 6 mg/ml and Latranculin A (Sigma), dissolved in ethanol, at 0.5 mM. Cells were treated with etoposide at 25 mM for 48 h to determine the susceptibility of the cells to apoptosis. To determine the specificity of integrin binding to a particular ECM, inhibitory integrin antibodies (Chemicon) were used. Appropriate blocking or stimulating antibodies of integrins used in this work are identified in parenthesis: a 2 (clone P1E6), b 1 (clone P4C10), b 1 stimulatory (TS2/16) for collagen-I binding; a 6 (clone NKIGoH3), b 4 (clone ASC-3) for laminin at a concentration of 4 mg/ml.
Immunofluorescence experiments
Cells were plated on ECM-coated chamber slides (Nunc) and allowed to adhere for 30 min at 371C. Cells were pretreated with 20 mM of Y-27632 compound for 30 min, as needed. After 30 min of binding, the slides were gently rinsed twice with PBS to remove unattached cells and fixed using 3.7% paraformaldehyde for 10 min. Cells were extracted with 0.5% Triton X-100 for 5 min, followed by three washes with PBS before blocking and hybridization with antibodies as described previously (Bharadwaj et al., 2004) . The samples were mounted using slow fade (Molecular Probes) to prevent fading. Images of the stained cells were captured using Zeiss LSM 510 confocal microscopy and imported into Adobe Photoshop (version 6.0). The magnification bars indicate 10 mm.
Flow cytometry
To determine the cell surface expression of integrins, subconfluent cell cultures were trypsinized, neutralized with media and were washed with PBS. All incubations were performed on ice to prevent internalization of the antibody. Cells were blocked in PBS containing 1% BSA for 1 h, incubated with integrin antibody (20 mg/ml) for another hour. The cells were collected by centrifugation (1000 g), washed twice with PBS containing 0.1% BSA and incubated in the dark with fluorochrome-conjugated secondary antibody for 1 h. Finally, the unbound secondary antibody was removed by washing thrice with PBS containing 0.1% BSA and resuspended at a concentration of 1 Â 10 6 cells/ml. The stained cells were immediately analysed by flow cytometry (BD FACS Star Plus).
Cell death assays
Cells (5 Â 10 5 ) were plated on poly-(2-hydroxyethyl methacrylate) (Poly-HEMA) (Sigma)-coated dishes (Raval et al., 2003) in serum-containing media, unless otherwise indicated. At the end of the culture (usually 6 or 24 h), cells were collected and several assays to determine apoptosis were performed. The DNA content of sub-G 0 -G 1 phase of cell cycle was determined using propidium iodide staining of ethanol-fixed cells (Raval et al., 2003) . Annexin V staining (BioVision) was performed according to the manufacturer's instruction and analysed by flow cytometry. The activation of caspases was monitored by immunoblotting. Cell counts were also taken at intervals to confirm cell death. Nuclear morphology of cells was determined by cytospinning 0.5-1.0 Â 10 4 cells on a slide and staining with DAPI (Sigma) at a concentration of 10 ng/ml (Raval et al., 2003) .
For visualizing cytochrome c release, a published protocol (Rosse et al., 1998) was used with some modifications. Briefly, cells grown in suspension for defined periods of time were cytospun onto slides and fixed with 3.7% paraformaldehyde for 10 min. After three washes with PBS, the cells were permeabilized with 0.05% saponin in PBS for 5 min followed by ice-cold acetone for 10 min. After three washes with PBS, the slide was blocked with 1% BSA in PBS for 30 min, incubated for 90 min with 1 : 50 dilution of anti-cytochrome c (clone 6H2.B4) in block solution and followed by 1 : 50 dilution of Rhodamine-conjugated goat-anti mouse (Molecular Probes) in block solution for 1 h. The cells were then postfixed for 10 min in 3.7% paraformaldehyde and processed as described for immunofluorescence experiments.
